Science and Enterprise

Category: Joint ventures/collaborations

  • University, Startup Develop Low-Power, High-Impact Display

    A collaboration between University of Cincinnati’s (UC’s) Novel Devices Laboratory, and startup company Gamma Dynamics LLC, also in Cincinnati, Ohio have created an electrofluidic display that provides a full color, high-impact image at a fraction of the power needed for current color hand-held and tablet devices. Electrofluidic displays use colored liquids to display the various…

  • Finnish Companies to Build Brazil R&D Center

    VTT Technical Research Centre in Espoo, Finland and Kemira Oyj, a water-quality management company in Helsinki, are opening a new joint R&D center in São Paulo, Brazil, focusing on water chemistry and biomass. The center will open at the end of 2010. The São Paulo R&D center is expected to implement new water technology research…

  • Trial Shows No Difference in Drugs for Macular Degeneration

    Researchers from the Boston University School of Medicine and the Veterans Affairs Boston Healthcare System in Jamaica Plain, Massacusetts have conducted a study that failed to show a difference in efficacy between the existing commercial drugs bevacizumab (Avastin) and ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD). The study, which appears in the…

  • Trial Shows Genital Herpes Vaccine Ineffective for Women

    The National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health in Bethesda, Maryland, reports that an experimental vaccine to prevent genital herpes disease in women, proved ineffective when tested in a recently concluded clinical trial. GlaxoSmithKline (GSK) Biologicals, based in Belgium, developed the vaccine it calls Simplirix. GSK announced today…

  • Sanofi-aventis, Covance to Partner on Drug Development

    Covance Inc., a drug development services company in Princeton, New Jersey, announced today an agreement with French pharmaceutical company Sanofi-aventis to provide drug development services to Sanofi-aventis over the next 10 years, with payments ranging from $1.2 billion to $2.2 billion. As part of the agreement, Sanofi-aventis will sell its Porcheville, France and Alnwick, United…

  • Biotech Company, Universities Produce Artificial Spider Silk

    A joint R&D project by University of Notre Dame in South Bend, Indiana, University of Wyoming in Laramie, and Kraig Biocraft Laboratories Inc. in Lansing, Michigan has succeeded in producing transgenic (genetically engineered) silkworms capable of spinning artificial spider silks. Natural spider silks have a number of unusual physical properties, including higher tensile strength and…

  • Innovation Challenge Yields Type-1 Diabetes Ideas

    A collaboration between Harvard University and innovation/crowdsourcing company InnoCentive generated nearly 200 ideas for new strategies to cure Type-1 diabetes, with the 12 winners announced yesterday by Harvard. The winners each received a $2,500 prize. The program was funded by an American Recovery and Reinvestment Act grant to Harvard Catalyst, the university’s cross-disciplinary clinical and…

  • U.K. Partnership to Research TB Testing Methods

    A collaboration between the National Physical Laboratory (NPL), the U.K.’s national measurement institute in Teddington, England and Orla Protein Technologies, a biotech company in Newcastle upon Tyne, England has been awarded £91,000 ($US 144,000) by the U.K. Technology Strategy Board to investigate improved methods for the detection of tuberculosis (TB). The U.S. Centers for Disease…

  • Dana-Farber, Sanofi-aventis Partner on Cancer Research

    Dana-Farber Cancer Institute’s Belfer Institute of Applied Cancer Science in Boston, Massachusetts and Sanofi-aventis, a global pharmaceutical company headquartered in Paris have struck a collaboration and license option agreement to identify and validate new oncology targets for further discovery and development by Sanofi-aventis. Dana-Farber’s Belfer Institute and Sanofi-aventis scientists will work together on discovering new…

  • NIH Foundation, Eli Lilly Launch US-Russia Science Partnership

    The Foundation for the National Institutes of Health (FNIH) in Bethesda, Maryland and Eli Lilly and Company in Indianapolis, Indiana have started a U.S.–Russia Forum in Health Sciences to encourage collaboration on shared priorities in health related research. FNIH is establishing the forum with a $1.3 million grant from Eli Lilly as the founding private…